The following definitions apply to this chapter, unless the context clearly indicates otherwise:
(1) "ADDD" or "automated drug dispensing device" includes, but is not limited to, a mechanical system controlled remotely by a pharmacist that performs operations or activities, related to the storage, counting, and dispensing of drugs to a credentialed health care professional consistent with their scope of practice. "ADDD" does not include technology that solely counts or stores, kiosks, robots, emergency kits, supplemental dose kits, or automation for compounding, administration, or packaging.
(2) "Blind count" means a physical inventory on the ADDD taken by a pharmacist or other Washington state credentialed health care professional acting within their scope of practice, as determined by the responsible manager, who performs a physical inventory without knowledge of or access to the quantities currently shown on electronic or other inventory systems.
(3) "Commission" means the Washington state pharmacy quality assurance commission.
(4) "Controlled substances" has the same meaning as defined in RCW
69.50.101.
(5) "Department" means the Washington state department of health.
(6) "Dispense" or "dispensing" means the interpretation of a prescription or order for a legend drug and, pursuant to that prescription or order, the proper selection, measuring, labeling, or packaging necessary to prepare that prescription or order for delivery. For purposes of part 1 of this chapter, dispensing by an ADDD does not include compounding.
(7) "Electronic verification system" means an electronic verification, bar code verification, radio frequency identification (RFID), weight verification, or similar electronic process that accurately verifies that medications have been properly dispensed by, labeled by, or loaded into an ADDD.
(8) "Legend drugs" has the same meaning as defined in RCW
69.41.010.
(9) "Override" means the process by which credentialed health care professionals, acting within their scopes of practice, are permitted to access and remove from an ADDD certain legend drugs, including controlled substances, prior to prospective drug utilization review and approval by a pharmacist.
(10) "Override list" means a list of medications, tailored to the health care facility based on the nature of care delivered, which are subject to retrieval without prospective drug utilization review.
(12) "Pharmacist" has the same meaning as defined in RCW
18.64.011.
(13) "Pharmacy technician" has the same meaning as defined in RCW
18.64A.010.
(14) "Prospective drug utilization review" means the evaluation and approval of medication orders by a pharmacist prior to administration of the first dose.
(15) "Replenishment" includes checking stock, loading, unloading, filling and refilling of medications in the ADDD.
(17) "Secure area" means that drugs are stored in a manner to prevent unmonitored access by unauthorized individuals.
(18) "Supervision" means overseen directly by a pharmacist, who is on the premises or indirectly by an electronic verification system for managing of ADDD inventory.